NASDAQ:LGVN
Longeveron Inc. Stock News
$1.75
+0.0800 (+4.79%)
At Close: Apr 26, 2024
MemeMoney: Some squeeze-loving retail investors are being cautious about all those shorts on Longeveron
06:02pm, Tuesday, 23'rd Nov 2021
It's never fair to paint all retail investors with the same brush, but it's also rather fair to say that pretty much all retail investors love themselves a short squeeze.
Pasithea Therapeutics, Petros Pharmaceuticals leads healthcare gainers; Longeveron, PainReform among major losers
03:57pm, Tuesday, 23'rd Nov 2021 Seeking AlphaLongeveron pares back gains after social media-driven rally
03:40pm, Tuesday, 23'rd Nov 2021 Seeking AlphaRetail Traders Jump Back Into Tiny Biotechs Ahead of Holiday - BNN Bloomberg
02:45pm, Tuesday, 23'rd Nov 2021 BNN Bloomberg
(Bloomberg) -- Two tiny biotechs, ISpecimen Inc. and Longeveron Inc., are the latest to see their stocks more than double in a social media-fueled frenzy ahead of a U.S. trading holiday.
Hot Stock Evaluation: Longeveron Inc. (NASDAQ:LGVN), Occidental Petroleum Corporation (NYSE:OXY)
10:26am, Tuesday, 23'rd Nov 2021 Stock Equity
Longeveron Inc. (LGVN) with the stream of 11.36% also noticed, India Occidental Petroleum Corporation (OXY) encountered a rapid change of 2.56% in the last hour of Mondays trading session. Longeveron The post Hot Stock Evaluation: Longeveron Inc. (NASDAQ:LGVN), Occidental Petroleum Corporation (NYSE:OXY) appeared first on Stocks Equity .
Longeveron (LGVN) Stock: Why The Price Surged
04:18am, Tuesday, 23'rd Nov 2021
The stock price of Longeveron Inc (NASDAQ: LGVN) increased by 181.16% in the most recent trading session. This is why it happened.
Longeveron momentum continues for a third day as shares up 151%
08:44pm, Monday, 22'nd Nov 2021 Seeking AlphaLongeveron stock vaults to another all-time high
08:42pm, Monday, 22'nd Nov 2021 MarketWatch
Longeveron shares jumped 117% to $21.62 on Monday to their highest level since the company went public in February at $10 a share. The stock has been rising sharply since Thursday, when the biotechnology company said its Lomecel-B for the treatment of a congenital heart defect in infants (Hypoplastic Left Heart Syndrome) affecting about 1,000 babies a year was granted rare pediatric disease (RPD) designation by the Food and Drug Administration. The stock catapulted 120% on Thursday and continued rising on Friday and Monday. Prior to the announcement, the stock''s highest price was about $8.45 a share on March 11 and a low of $2.84 a share earlier this year. Volume on the stock hit 98 million shares on Monday, compared to its average daily volume of 110,000 shares. Even with the share price boost, Longeveron''s market cap remans small at about $192 million. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
4 Biotech Stocks To Watch This Week
01:58pm, Monday, 22'nd Nov 2021
Could these biotech stocks be poised for long-term gains?
What Do Analysts Recommend? Longeveron Inc. (NASDAQ:LGVN), The Coca-Cola Company (NYSE:KO)
03:11am, Monday, 22'nd Nov 2021 Stock Equity
Longeveron Inc. (LGVN) with the stream of 46.00% also noticed, India The Coca-Cola Company (KO) encountered a rapid change of -0.51% in the last hour of Fridays trading session. Longeveron The post What Do Analysts Recommend? Longeveron Inc. (NASDAQ:LGVN), The Coca-Cola Company (NYSE:KO) appeared first on Stocks Equity .
Longeveron (LGVN) Stock: Why The Price Surged Today
08:18pm, Sunday, 21'st Nov 2021
The stock price of Longeveron Inc (NASDAQ: LGVN) increased by 46% in the most recent trading session. This is why it happened.
Longeveron up 100% after FDA approves its Lomecel-B medical product
05:48pm, Friday, 19'th Nov 2021 Invezz
Longeveron Inc (NASDAQ: LGVN) is a clinical biotech firm that develops cellular therapies to treat life-threatening and aging-related conditions. It announced that it had received approval from the FDA for the RPD (Rare Pediatric Disease) designation for its Lomecel-B to treat Hypoplastic Left Heart Syndrome. HLHS is a life-threatening and rare congenital heart complication in infants. []
The post Longeveron up 100% after FDA approves its Lomecel-B medical product appeared first on Invezz.
Why Did Longeveron''s Stock Just Spike?
05:08pm, Friday, 19'th Nov 2021 GuruFocus
The biotech company''s core Lomecel-B cellular therapy has made progress on regulatory approvals Related Stocks: LGVN ,
Longeveron, SCYNEXIS leads healthcare gainers; Connect Biopharma, Flora Growth among major losers
04:30pm, Friday, 19'th Nov 2021 Seeking AlphaLongeveron up 100% after FDA approves its Lomecel-B medical product
12:48pm, Friday, 19'th Nov 2021
Longeveron Inc (NASDAQ: LGVN) is a clinical biotech firm that develops cellular therapies to treat life-threatening and aging-related conditions. It announced that it had received approval from the F